Your browser doesn't support javascript.
loading
CIGB-300-Regulated Proteome Reveals Common and Tailored Response Patterns of AML Cells to CK2 Inhibition.
Rosales, Mauro; Rodríguez-Ulloa, Arielis; Pérez, George V; Besada, Vladimir; Soto, Thalia; Ramos, Yassel; González, Luis J; Zettl, Katharina; Wisniewski, Jacek R; Yang, Ke; Perera, Yasser; Perea, Silvio E.
Afiliación
  • Rosales M; Department of Animal and Human Biology, Faculty of Biology, University of Havana (UH), Havana, Cuba.
  • Rodríguez-Ulloa A; Molecular Oncology Group, Department of Pharmaceuticals, Biomedical Research Division, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
  • Pérez GV; Mass Spectrometry Laboratory, Proteomics Group, Department of System Biology, Biomedical Research Division, CIGB, Havana, Cuba.
  • Besada V; Molecular Oncology Group, Department of Pharmaceuticals, Biomedical Research Division, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
  • Soto T; Mass Spectrometry Laboratory, Proteomics Group, Department of System Biology, Biomedical Research Division, CIGB, Havana, Cuba.
  • Ramos Y; Department of Animal and Human Biology, Faculty of Biology, University of Havana (UH), Havana, Cuba.
  • González LJ; Molecular Oncology Group, Department of Pharmaceuticals, Biomedical Research Division, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.
  • Zettl K; Mass Spectrometry Laboratory, Proteomics Group, Department of System Biology, Biomedical Research Division, CIGB, Havana, Cuba.
  • Wisniewski JR; Mass Spectrometry Laboratory, Proteomics Group, Department of System Biology, Biomedical Research Division, CIGB, Havana, Cuba.
  • Yang K; Biochemical Proteomics Group, Department of Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, Munich, Germany.
  • Perera Y; Biochemical Proteomics Group, Department of Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, Munich, Germany.
  • Perea SE; China-Cuba Biotechnology Joint Innovation Center (CCBJIC), Yongzhou Zhong Gu Biotechnology Co., Ltd., Yongzhou, China.
Front Mol Biosci ; 9: 834814, 2022.
Article en En | MEDLINE | ID: mdl-35359604
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Mol Biosci Año: 2022 Tipo del documento: Article País de afiliación: Cuba Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Mol Biosci Año: 2022 Tipo del documento: Article País de afiliación: Cuba Pais de publicación: Suiza